News | February 03, 2026
Artemis Medicare reports strong Q3 growth: revenue up 17%, net profit up 8%
Nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh
Nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
The company recorded consolidated revenue of Rs. 660 crore in Q3 FY26, up
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
Company to launch product after the expiry of semaglutide patent in India
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
